250 related articles for article (PubMed ID: 28738934)
1. Neoadjuvant Talimogene Laherparepvec for the Treatment of Metastatic Melanoma.
Stiles ZE; Fleming MD; Luce EA; Deneve JL
Am Surg; 2017 Jul; 83(7):e266-268. PubMed ID: 28738934
[No Abstract] [Full Text] [Related]
2. Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab.
Naqash AR; Stroud G; Collichio FA; Muzaffar M; Sharma N; Walker P
Acta Oncol; 2017 Oct; 56(10):1327-1330. PubMed ID: 28481677
[No Abstract] [Full Text] [Related]
3. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
Wilson LL
Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Andtbacka RH; Agarwala SS; Ollila DW; Hallmeyer S; Milhem M; Amatruda T; Nemunaitis JJ; Harrington KJ; Chen L; Shilkrut M; Ross M; Kaufman HL
Head Neck; 2016 Dec; 38(12):1752-1758. PubMed ID: 27407058
[TBL] [Abstract][Full Text] [Related]
5. Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma.
Newlands C; Gurney B
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):301-7. PubMed ID: 24565440
[TBL] [Abstract][Full Text] [Related]
6. Epitrochlear lymph node basin in melanoma: an extension of the axillary station or an independent basin?
Cozzaglio L; Marazzi F; Quagliuolo V
Updates Surg; 2018 Dec; 70(4):573-574. PubMed ID: 29520696
[No Abstract] [Full Text] [Related]
7. Complete pathologic response after neoadjuvant treatment with vemurafenib for malignant melanoma.
Kaidar-Person O; Eran A; Bar-Sela G
J Am Acad Dermatol; 2014 Feb; 70(2):e39-41. PubMed ID: 24438978
[No Abstract] [Full Text] [Related]
8. Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.
Koers K; Francken AB; Haanen JB; Woerdeman LA; van der Hage JA
J Clin Oncol; 2013 Jun; 31(16):e251-3. PubMed ID: 23569313
[No Abstract] [Full Text] [Related]
9. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
10. Assessment of second tier lymph nodes in melanoma and implications for extent of elective neck dissection in metastatic cutaneous malignancy of the parotid.
Ch'ng S; Pinna A; Ioannou K; Juszczyk K; Shannon K; Clifford A; Uren R; Clark JR
Head Neck; 2013 Feb; 35(2):205-8. PubMed ID: 22290612
[TBL] [Abstract][Full Text] [Related]
11. The safety of talimogene laherparepvec for the treatment of advanced melanoma.
Gangi A; Zager JS
Expert Opin Drug Saf; 2017 Feb; 16(2):265-269. PubMed ID: 27989216
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography evaluation of oncolytic virus therapy efficacy in melanoma.
Franke V; van der Hiel B; van de Wiel BA; Klop WMC; Ter Meulen S; van Akkooi ACJ
Eur J Cancer; 2018 Feb; 90():149-152. PubMed ID: 29224902
[No Abstract] [Full Text] [Related]
13. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Hafner J
Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
[No Abstract] [Full Text] [Related]
14. A glimpse of future management of melanoma.
Cochran AJ
Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
[No Abstract] [Full Text] [Related]
15. Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma.
Garnock-Jones KP
BioDrugs; 2016 Oct; 30(5):461-468. PubMed ID: 27516203
[TBL] [Abstract][Full Text] [Related]
16. An aberrant lymph node containing metastatic melanoma detected by sentinel node biopsy.
Moloney DM; Overstall S; Allan R; Powell BW
Br J Plast Surg; 2001 Oct; 54(7):638-40. PubMed ID: 11583504
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective.
Queirolo P; Taveggia P; Gipponi M; Sertoli MR
J Surg Oncol; 2004 Mar; 85(3):162-5. PubMed ID: 14991888
[TBL] [Abstract][Full Text] [Related]
18. The role of sentinel lymph node biopsy in the management of thin melanoma.
Wong SL
Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
20. Complication rates of completion lymphadenectomy following positive sentinel lymph node biopsy versus therapeutic lymphadenectomy in melanoma.
Smith JR; Wilson A; Stone C
J Plast Reconstr Aesthet Surg; 2016 Jul; 69(7):1011-2. PubMed ID: 27184594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
